Influenzinum (Ratis, LLC)


Welcome to the PulseAid listing for the Influenzinum drug offered from Ratis, LLC. This pharmaceutical is classified as a HUMAN OTC DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN OTC DRUG drug type category.
LABELER NAME / MANUFACTURER: Ratis, LLC
NON-PROPRIETARY NAME: Influenzinum (2017-2018)
SUBSTANCE NAME: INFLUENZA A VIRUS A/SINGAPORE/GP1908/2015 IVR-180A (H1N1) ANTIGEN (PROPIOLACTONE INACTIVATED); INFLUENZA A VIRUS A/HONG KONG/4801/2014 X-263B (H3N2) ANTIGEN (PROPIOLACTONE INACTIVATED); INFLUENZA B VI
TYPE: HUMAN OTC DRUG
PHARMA CLASS:
ROUTE: ORAL
DOSAGE FORM: SPRAY
MARKETING CATEGORY NAME: UNAPPROVED HOMEOPATHIC
START MARKETING DATE: 2017-10-03
END MARKETING DATE: 0000-00-00


Influenzinum HUMAN OTC DRUG Details:

Item DescriptionInfluenzinum from Ratis, LLC
LABELER NAME: Ratis, LLC
DEA SCHEDULE:
ACTIVE STRENGTH: 9; 9; 9([hp_C]/mL; [hp_C]/mL; [hp_C]/mL)
START MARKETING DATE: 2017-10-03
END MARKETING DATE: 0000-00-00
PRODUCT ID: 71753-1050_adc5da38-5f95-41ee-b009-120920d74c58
PRODUCT NDC: 71753-1050
APPLICATION NUMBER:

Other INFLUENZA A VIRUS A/SINGAPORE/GP1908/2015 IVR-180A (H1N1) ANTIGEN (PROPIOLACTONE INACTIVATED); INFLUENZA A VIRUS A/HONG KONG/4801/2014 X-263B (H3N2) ANTIGEN (PROPIOLACTONE INACTIVATED); INFLUENZA B VI Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Energique, Inc.Influenzinum
Ratis, LLCInfluenzinum
Seqirus Pty LtdAFLURIA